Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




China's Anti-Doping Agency Prepares for Olympic Games

By Labmedica staff writers
Posted on 05 Jun 2008
The China Anti-Doping Agency (Beijing, China) will examine more than 4,500 samples from athletes for banned drugs during the 2008 Olympic Games.

Three leadership delegations so far from the Chinese agency have been hosted by Agilent Technologies Inc. More...
The meetings include technical training on anti-doping instruments and methods developed by Agilent (Santa Clara, CA, USA), a primary supplier of technology to China's Anti-Doping Agency since 1988.

The agency has equipped its Beijing lab with Agilent liquid chromatography (LC), gas chromatography (GC), and mass spectrometry (MS) instruments to confirm the chemical identity of suspected banned substances found in testing samples. Agilent is providing 18 LC/MS units and 19 GC/MS units for drug testing at the Games.

"China has quickly become a world model for anti-doping efforts,” said Du Lijun, director of China's Anti-Doping Agency. "Agilent's liquid chromatography and mass spectrometry instrumentation will help make China's Anti-Doping Agency testing in the 2008 Olympic Games the most technologically advanced yet.”


Related Links:
China Anti-Doping Agency
Agilent

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.